PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,336 | -72.7% | 149,600 | -67.2% | 0.00% | – |
| Q2 2023 | $911,128 | -17.2% | 455,564 | -13.0% | 0.00% | – |
| Q1 2023 | $1,100,190 | +91.1% | 523,900 | +24.6% | 0.00% | – |
| Q4 2022 | $575,811 | -0.0% | 420,300 | -24.2% | 0.00% | – |
| Q3 2022 | $576,000 | +16.8% | 554,561 | +22.7% | 0.00% | – |
| Q2 2022 | $493,000 | +40.9% | 452,100 | +36.7% | 0.00% | – |
| Q1 2022 | $350,000 | +9.4% | 330,619 | -13.9% | 0.00% | – |
| Q4 2021 | $320,000 | -65.2% | 383,900 | -44.5% | 0.00% | – |
| Q3 2021 | $919,000 | -57.2% | 691,271 | -38.5% | 0.00% | – |
| Q2 2021 | $2,148,000 | +7.7% | 1,124,545 | +151.5% | 0.00% | – |
| Q1 2021 | $1,994,000 | +74.9% | 447,113 | +42.5% | 0.00% | – |
| Q4 2020 | $1,140,000 | +461.6% | 313,778 | +497.7% | 0.00% | – |
| Q3 2020 | $203,000 | -67.7% | 52,500 | -68.4% | 0.00% | – |
| Q2 2020 | $629,000 | +914.5% | 165,900 | +533.2% | 0.00% | – |
| Q1 2020 | $62,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spire Wealth Management | 148,800 | $158,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
| Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
| IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
| Smith, Salley & Associates | 12,048 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |